Novartis Unit Accused of ‘Massive Fraud’ in State Lawsuit

(Bloomberg) -- Novartis AG’s Sandoz unit was at the center of a sweeping conspiracy with competitors to raise prices of generic drugs by more than 1,000%, according to the latest U.S. lawsuit by st...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.